Differences between Belgian and Brazilian Group A Streptococcus Epidemiologic Landscape by Smeesters, Pierre Robert et al.
Differences between Belgian and Brazilian Group A
Streptococcus Epidemiologic Landscape
Pierre Robert Smeesters
1,2,3*, Anne Vergison
1,4, Diocle ´cio Campos
3, Eurico de Aguiar
5, Veronique Yvette Miendje Deyi
6, Laurence Van
Melderen
2
1Infectious Diseases Department, Ho ˆpital Universitaire des Enfants Reine Fabiola, Universite ´ Libre de Bruxelles, Brussels, Belgium, 2Laboratoire de
Ge ´ne ´tique des Procaryotes, Institut de Biologie et de Me ´decine Mole ´culaires, Universite ´ Libre de Bruxelles, Brussels, Belgium, 3Pediatric Department,
Hospital Universita ´rio de Brası ´lia, Universidade de Brası ´lia, Brası ´lia, Brazil, 4Epidemiology and Infection Control Unit, Ho ˆpital Universitaire des Enfants
Reine Fabiola, Universite ´ Libre de Bruxelles, Brussels, Belgium, 5Microbiology Department, Hospital Regional da Asa Sul, Brası ´lia, Brazil, 6Microbiology
Department, Centre Hospitalier Universitaire Brugmann, Universite ´ Libre de Bruxelles, Brussels, Belgium
Background. Group A Streptococcus (GAS) clinical and molecular epidemiology varies with location and time. These
differences are not or are poorly understood. Methods and Findings. We prospectively studied the epidemiology of GAS
infections among children in outpatient hospital clinics in Brussels (Belgium) and Brası ´lia (Brazil). Clinical questionnaires
were filled out and microbiological sampling was performed. GAS isolates were emm-typed according to the Center for
Disease Control protocol. emm pattern was predicted for each isolate. 334 GAS isolates were recovered from 706 children.
Skin infections were frequent in Brası ´lia (48% of the GAS infections), whereas pharyngitis were predominant (88%) in
Brussels. The mean age of children with GAS pharyngitis in Brussels was lower than in Brası ´lia (65/92 months, p,0.001).
emm-typing revealed striking differences between Brazilian and Belgian GAS isolates. While 20 distinct emm-types were
identified among 200 Belgian isolates, 48 were found among 128 Brazilian isolates. Belgian isolates belong mainly to emm
pattern A–C (55%) and E (42.5%) while emm pattern E (51.5%) and D (36%) were predominant in Brası ´lia. In Brası ´lia, emm
pattern D isolates were recovered from 18.5% of the pharyngitis, although this emm pattern is supposed to have a skin
tropism. By contrast, A–C pattern isolates were unfrequently recovered in a region where rheumatic fever is still highly
prevalent. Conclusions. Epidemiologic features of GAS from a pediatric population were very different in an industrialised
country and a low incomes region, not only in term of clinical presentation, but also in terms of genetic diversity and
distribution of emm patterns. These differences should be taken into account for designing treatment guidelines and
vaccine strategies.
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INTRODUCTION
The incidence of Group A Streptococcus (GAS) diseases vary with
location and time. Rheumatic fever is still a major cause of
cardiovascular morbidity and mortality in developing countries
[1,2], while it has become uncommon in the industrialized world.
Pharyngitis occurs predominantly during the cold season in
temperate climates and is less frequent in tropical regions [3].
By contrast, skin infections are described at a much higher rate in
developing countries than in rich western nations [3,4]. These
epidemiological differences are not or poorly understood.
Molecular GAS typing (emm typing) is based on the 59 end
sequence of the emm gene that encodes the hyper variable amino-
terminal part of the M protein. This surface protein is a major
virulence factor and acts as a protective antigen [5]. Currently,
more than 170 recognized emm-types, constituting more than 750
sub-types, have been described (http://www.cdc.gov/ncidod/
biotech/strep/emmtypes.htm). Molecular epidemiological data
are available for Western countries where a limited number of
specific emm-types are predominant. Although few comprehensive
and prospective studies have been performed in developing
countries [1], a high diversity of emm-types has been described in
certain locations [6–9].
The emm pattern serves as a genotypic marker to classify GAS
strains according to their tissue tropism (skin or throat). It is based
on the organization of emm and emm-like genes located in the mga
locus [10,11]. The emm pattern A–C strains are usually recovered
from the throat isolates, whereas strains presenting an emm pattern
D are most often isolated from the skin. ‘‘Generalist’’ emm pattern
E strains are associated with both tissue sites. Rheumatic fever has
been historically associated with strains belonging to emm pattern
A–C [12]. However, the correlation between emm pattern and site
of isolation has not always been confirmed in developing countries,
where rheumatic fever is still endemic [9,11]. In Nepal, for
instance, A–C strains were preferentially recovered from skin
infections [9]. These data indicate no definitive association
between GAS emm pattern groups and the site of infection and/
or the ability to cause a specific disease.
These epidemiological differences prompted us to conduct
a comparative study between an industrialized country (Belgium)
and a developing country (Brazil).
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1) Clinical Epidemiology
706 children (360 in Brussels, 346 in Brası ´lia) with various
streptococcal manifestations were included in the study. No
significant difference in the mean number of children under the
same roof was observed between Brası ´lia (2.2 children) and
Brussels (2 children). 334 GAS isolates (204 in Brussels, 161 of
which were reported from the laboratory and clinical data
completed retrospectively; and 130 in Brası ´lia) were recovered
from the 706 children. In Brussels, 94% of the GAS isolates were
recovered from the throat or external ear (pharyngitis, scarlet fever
and otitis) while cutaneous infections were rare (3%). We observed
two GAS invasive infections. In Brası ´lia, GAS were isolated
equally from cutaneous infections and pharyngitis. There were 5
GAS invasive infections and 1 sequela (post-streptococcal
glomerulonephritis).
Risk factors for pharyngitis and impetigo The percentage
of clinically diagnosed pharyngitis associated with GAS positive
culture was higher in Brası ´lia (26%) than in Brussels (20%)
(p=0,13). In Brası ´lia, the percentage of positive culture varied
with the age of children: 32%, 18% and 0% of the children older
than 59 months, from 36 to 59 month old and under 36 month
old presented a GAS pharyngitis respectively (p=0.003) (Figure 1).
In Brussels, the prevalence of GAS pharyngitis was unchanged
from 15 month old to 13 year old. The mean age of children with
GAS pharyngitis was 7.6 year old (ranging from 38 to
153 months) in Brası ´lia and 5.4 year old (ranging from 15 to
150 months) in Brussels (p,0.001). Nutrition indices, crowding,
sex or previous antibiotherapy did not constitute a risk for GAS
pharyngitis in both Brussels and Brası ´lia.
61% of impetigo were associated with a GAS positive culture in
Brası ´lia. These streptococcal skin infections were not related to
age, sex, crowding, nutrition indices and previous antibiotic
treatment during the last six months. The small number of
impetigo in Brussels did not allow any statistical analyses.
2) Molecular Epidemiology
emm-types and emm-patterns distribution The emm-type
was successfully determined for 200 of the 204 Belgian isolates and
128 of the 130 Brazilian ones. Among the 200 isolates recovered in
Brussels, 20 different emm-types were identified (figure 2 and table
S1). A predominance of 6 emm-types, which accounted for 75% of
the isolates, was observed in Brussels (emm 6 (20%), emm 1 (14%),
emm 12 (12%), emm 89 (11%), emm 4 (11%) and emm 3 (8%)). 55%
and 42.5% of the GAS isolates were classified into emm patterns
A–C and E respectively, whereas only 0.5% presented an emm
pattern D.
Among the 128 isolates recovered in Brası ´lia which were typed,
48 different emm-types were identified (figure 2 and table S2). None
of these emm-type was predominant. The most frequent emm-type
(emm 53) represented only 8.5% of the Brazilian isolates. The 6
most prevalent emm-types (emm 53, emm 22, emm 49, emm 58, emm
83, emm 8) among the Brazilian GAS isolates accounted for only
36% of the total number of GAS isolates and nearly half of the
emm-types (22/48) were represented by a single isolate. emm
patterns E, D and A-C accounted for 51.5%, 36% and 9.5% of the
Brazilian isolates respectively.
15 emm-types (emm 1, emm 2, emm 3, emm 4, emm 6, emm 11, emm
12, emm 28, emm 44/61, emm 58, emm 64, emm 75, emm 87, emm 94
and emm st1815) were recovered from children in both Brussels
(15/20 emm-types, 84% of the isolates) and Brası ´lia (15/48, 27% of
the isolates).
New emm sub-types 8 new emm sub-types were identified.
The 6 Brazilian new emm sub-types represented 7% of the isolates.
They differed from the reference strains by a single nucleotide
change. In Brussels, we found 2 new sub-types. One differed by
a single substitution and the other by a 7 nucleotides change from
the reference strains.
emm-types, emm-pattern, clinical presentation and site
preference emm pattern A–C strains are commonly found in the
throat, whereas emm pattern D strains are most often isolated from
skin lesions. emm pattern E is considered as ‘‘generalist’’: It is
readily found at both tissue sites. Among the Brazilian isolates, the
relative risk for emm pattern A–C to be a throat isolate rather than
a skin isolate was 1.68 (95% CI, 1.04–2.20). emm pattern D isolates
had a relative risk to be recovered from skin rather than from
throat of 2.16 (95% CI, 1.53–3.08). However, more emm pattern D
than A–C were isolated from the throat of Brazilian children. A
comparison of the emm pattern displayed by pharyngeal isolates
recovered in both capitals is showed in Figure 3. The distribution
of emm-pattern among Brazilian skin isolates showed a classical
predominance of emm pattern D (55%) and E (42%) with few A–C
(3%). In order to compare the emm pattern from the most relevant
isolates from the two cities, the emm-types that were represented by
a minimum of 3 isolates were selected (18/48 Brazilian emm-types
Figure 1. Distribution of GAS pharyngitis according to age in Brussels and Brası ´lia. Percentage of positive GAS throat culture for different age
categories of children with pharyngitis. p=0,003 for the comparison between the three age groups in Brası ´lia.
doi:10.1371/journal.pone.0000010.g001
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was recovered from both cutaneous and pharyngeal sites was 66%
(n=12) in Brası ´lia and 31% (n=5) in Brussels. These emm-types
were constituted mainly by emm pattern E (Brası ´lia and Brussels,
n=7 and 3 respectively), but also emm pattern D (only in Brası ´lia,
n=4) and A–C (in Brası ´lia and Brussels, n=1 and 2 respectively ).
The 2 cases of invasive infections in Brussels were caused by emm
1 and 3 strains belonging to the emm pattern A–C. By contrast,
invasive infections in Brası ´lia were associated with different emm-
types (1, 49, 80, 87, st213 and st 6735), belonging to the three
different emm pattern (E (n=4), D (n=1) and A–C (n=1)).
DISCUSSION
This comparative study illustrates how GAS epidemiology features
vary greatly in clinical and molecular aspects between two cities
with different history, climate and socio-economical situation,
although both performed in underprivileged populations attending
public hospitals.
No GAS was isolated in children under 3 year-old in Brası ´lia,
while in Brussels, the GAS prevalence was similar in the 1 to
3 year-old group and in older children [14]. This contrasts with
previous studies showing that the incidence of GAS pharyngitis
was lower in children younger than 5 year-old than in older
children [15]. Moreover, Belgian children with GAS pharyngitis
were younger than Brazilian ones. Differences in day care
attendance, administrated vaccines and antibiotics consumption
in the first years of life might contributed to the variations we
observed, as these factors can modify the naso-pharyngeal flora.
In the Belgian children, GAS infections were mostly attributable
to emm pattern A–C and E strains. In Brası ´lia, the emm pattern A–
C was rarer than in Brussels while emm pattern D was much more
frequent. The predominance of emm pattern D strains in tropical
Figure 2. emm-types distribution in Brussels and Brası ´lia. The distribution of the emm-types is oligoclonal in Brussels (20 emm-types among 200
isolates) and polyclonal in Brası ´lia (48 emm-types among 128 isolates). Moreover, the emm-types involved were different.
doi:10.1371/journal.pone.0000010.g002
Figure 3. emm pattern of pharyngeal GAS in Brussels and Brası ´lia. emm pattern A–C strains are throat specific, whereas emm pattern D strains have
a skin tropism. emm pattern E strains are found at both sites. In Brussels, strains with emm patterns A–C (56%) and E (41.5%) were predominant
among strains isolated from naso-pharynx (pharyngitis and scarlet fever included). In Brası ´lia, the A–C pattern was rare (14%) amongst pharyngeal
strains while E pattern (61.5%) and D pattern (18.5%) were predominant. REA: rearranged emm region.
doi:10.1371/journal.pone.0000010.g003
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Brazilian emm pattern D strains, which classically have a skin
tropism, presented interesting characteristics: (i) emm pattern D
strains were recovered in one fifth (18.5%) of the isolates collected
from the throat of Brazilian children. (ii) one third of the ‘‘non
unique’’ Brazilian emm-types (which were represented by a mini-
mum of 3 isolates) recovered from both throat and skin sites
belonged to emm pattern D. (iii) emm pattern D strains (emm 53.0)
were simultaneously isolated from the skin and the throat of two
children presenting a sore throat associated with a skin infection.
Some emm pattern D could therefore be considered as ‘‘generalist’’
with variable skin tropism. Similar findings were found in Ethiopia
[7] and Nepal [9], where the emm pattern D strains were equally
isolated from the skin and the throat. Previous studies showed that
emm pattern D strains presented (with emm pattern E) the higher
level of emm-type and multilocus sequence type (ST) diversity
among the different emm pattern [10]. Recombination events
appeared to be the most frequent in emm pattern D strains and
included replacement of the emm-type locus [10]. Similarly,
multilocus sequence typing identified substantial genetic recombi-
nation between the so-called skin and throat strains as well as
various new combinations of emm and housekeeping genes in
a small community with high rates of rheumatic fever and GAS
impetigo [17]. Some emm pattern D strains might have evolved to
acquire the capacity to colonize and/or infect both cutaneous and
pharyngeal environment and therefore cause rheumatic fever. In
Brası ´lia, where rheumatic fever is endemic (Rheumatic fever was
responsible of one third of the Brazilian heart surgeries in 2004;
data from the Brazilian ministry of Health, Sistema U ´nico de
Sau ´de (SUS) - Ministe ´rio da Sau ´de), GAS skin infections were
frequent and emm pattern D strains were more ‘‘generalist’’ than
previously thought. Moreover, the A–C strains (classically associated
with rheumatic fever) were rarely isolated. These findings are in
agreement with the possible link between cutaneous strains and
rheumatic fever in some epidemiological contexts. Indeed, if in
temperate regions, rheumatic fever appears to be associated
exclusively with throat infections, recent data suggested that GAS
impetigo strains are probably involved directly or indirectly in acute
rheumatic fever in particular communities [11,16,17]. In Ethiopia,
emm pattern D strains were over represented (57%; 4/7) in the
isolates associated with rheumatic fever [7]. Skin infections might
constitute the GAS reservoir which triggers auto-immune reaction
with or without secondary throat colonisation.
The high rate of rheumatic fever in Brası ´lia could also be
associated with the impressive emm-types diversity we observed (48
emm-types over 128 isolates). This wide variety of emm-type
circulating in Brası ´lia is probably responsible for a great diversity
of anti-M proteine antibodies, hence increasing the risk for
autoimmune response. Reports of GAS epidemiology outside
Western nations are scarce but contradictory. Some of them
(Korea, Mexico and aboriginal Australian) show the presence of
a few predominant emm-types [11,18,19]. In other countries (India,
Ethiopia and Nepal), a high diversity of emm-types was reported
[6–9], although they were different from one location to the other.
The studies showing a highly polyclonal distribution were
performed in locations where massive and recent human
migrations occurred. The city of Brası ´lia was built in a poor
deserted region 45 years ago. The population of Brası ´lia, which
has become one of the most developed city of the country, is now
about 2 millions and immigrated from the whole country. The
resulting diversity of hosts might contribute to the diversity of emm-
types. By contrast with the Brazilian data, the emm-type
distribution in Brussels was oligoclonal as typically seen in western
countries [20].
This comparative study suggests that differences in the selective
pressure between industrialised and low incomes regions of the
world could favour the genetic evolution of GAS emm-types and
therefore their emergence and/or persistence. Further studies are
needed to clarify these differences and their impact for the
prevention of GAS infections and sequelae. The theoretical
coverage of the 26 valent GAS vaccine [21] would be 76% in
Brussels whereas in Brası ´lia, it would be as low as 32%. This low
theoretical coverage is similar to that reported in the studies from
India, Ethiopia and Nepal. This is of particular relevance as these
countries are those who could most benefit from a GAS vaccine.
MATERIALS & METHODS
We prospectively studied the epidemiology of GAS infections from
February 1 to October 31, 2004 in children from Brussels and
Brası ´lia.
Patients
Patients 0–15 year old attending 3 public hospitals of Brası ´lia
(Hospital Universita ´rio de Brası ´lia, Hospital Regional da Asa Sul
and Unidade mixta de Saude de Sa ˜o Sebastia ˜o with 250, 180 and
40 beds respectively) and one public hospital of Brussels (Ho ˆpital
Universitaire des Enfants Reine Fabiola with 170 beds) were
included in this study. This study was approved by the ethical
board of all participant hospitals. An informed consent was
obtained from each child’s parent or guardian. Inclusion criteria
were any infections with clinical suspicion of GAS aetiology or
GAS isolation by the laboratory. Exclusion criterion was a current
antimicrobial treatment. A pre-designed form was filled out by the
pediatricians with personal, epidemiological and clinical data.
GAS pharyngitis, cutaneous infections and otitis were defined as
a positive GAS culture associated with symptoms of sore throat,
impetigo and discharge from ear respectively. Scarlet fever was
considered as clinically distinct from pharyngitis. Invasive infec-
tions were defined by a GAS isolation from a normally sterile body
site. Post-streptococcal glomerulonephritis and acute rheumatic
fever were defined according to published criteria [13]. Physicians
were trained to swab with a standardised technique. No clinical
follow-up was achieved.
Collection and isolation
Samples were plated on blood agar (5%) and were incubated at
37uC for 24–48H in the presence of 5% CO2. Bloodcultures were
incubated (BactecH, Becton Dickinson, Frankin Lakes, United
States) at 37uC for seven days. Beta haemolytic streptococci were
phenotypicaly identified by beta haemolysis on blood agar, colony
morphology, gram stain, catalase reaction and sensitivity to
0.04 U bacitracin disk. GAS identification was performed with
a positive latex agglutination test containing group A specific
antisera (Slidex; Biome ´rieux, Paris, France).
emm typing
emm-typing of all isolates was performed according to the protocol
described by the Center for Disease Control (CDC; http://www.
cdc.gov/ncidod/biotech/strep/protocols.html). Primer 1 (59-TAT
TCG CTT AGA AAA TTA A-39) and primer 2 (59-GCA AGT
TCT TCA GCT TGT TT-39) or primer MF2 (59-GGA TCC
ATA AGG AGC ATA AAA ATG GCT A-39) and MR1 (59-TGA
TAG CTT AGT TTT CTT CTT TGC GTT TT-39) were used
to amplify the 59 region of the emm gene as described by the CDC.
emmseq2 primer (59-TAT TCG CTT AGA AAA TTA AAA
ACA GG-39) and MF2 were used for sequencing. The sequences
were compared to those in the databases available on the CDC
GAS Epidemiology Differences
PLoS ONE | www.plosone.org 4 December 2006 | Issue 1 | e10website (http://www.cdc.gov/ncidod/biotech/strep/strepblast.
htm) and in GenBank (fttp://www.ncbi. nlm.nih.gov/BLAST/).
New sequences were submitted to the CDC streptococcal database
and to GenBank (accession number: emm 5.50, DQ 114470; emm
12.30, DQ 114469; emm st 2940.2, DQ 006844; emm 53.5, DQ
006846; emm 73.5, DQ 006845; emm 64.5, DQ 020479; emm 94.2,
DQ 026516; emm 98.2, DQ 020480).
emm pattern
GAS isolates within a given emm type usually display the same emm
pattern [10].The emm pattern for each isolate was predicted
according to McGregor et al., 2004 [10].
Statistical Analysis:
Bilateral chi-square and student t test (SPSS 11.0, Gaussian
distribution) were performed to compare general data and
nutrition indices. p values,0.05 were considered significant.
SUPPORTING INFORMATION
Table S1 emm-types, sub-type and pattern by clinical presenta-
tion in Brussels.REA: rearranged, Empy: empyeme, TSS: toxic
shock syndrome, RF: rheumatic fever, Vag: vaginal infection, Uri:
urinar infection, Ocu: ocular infection.
Found at: doi:10.1371/journal.pone.0000010.s001 (0.11 MB
DOC)
Table S2 emm-types, sub-type and pattern by clinical pre-
sentation in Brası ´lia.REA: rearranged, TSS: toxic shock syn-
drome, Cell: celulitis
Found at: doi:10.1371/journal.pone.0000010.s002 (0.17 MB
DOC)
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